Pyrrolidine dithiocarbamate attenuates brain Aβ increase and improves long-term neurological outcome in rats after transient focal brain ischemia

Neurobiology of Disease

Volumn 45, Issue 1, 2012, Pages 564-572

  Li, Jiejie ^a,b   Sheng, Wenli ^b   Feng, Chenzhuo ^a   Zuo, Zhiyi ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

amyloid peptide; Cognition; Focal brain ischemia; Pyrrolidine dithiocarbamate

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; INSULINASE; MEMBRANE METALLOENDOPEPTIDASE; PYRROLIDINE DITHIOCARBAMATE;

ADULT ANIMAL; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; LEARNING DISORDER; MALE; MEMORY DISORDER; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; SPRAGUE DAWLEY RAT; TRANSIENT ISCHEMIC ATTACK;

AMYLOID BETA-PEPTIDES; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; ISCHEMIC ATTACK, TRANSIENT; MALE; MAZE LEARNING; MEMORY; MOTOR ACTIVITY; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; THIOCARBAMATES;

EID: 81955164209     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.09.013     Document Type: Article

References (43)

1. Craft J.M., Van Watterson D.M., Eldik L.J. Human amyloid beta-induced neuroinflammation is an early event in neurodegeneration. Glia 2006, 53:484-490.
2. Finder V.H., Vodopivec I., Nitsch R.M., Glockshuber R. The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42. J. Mol. Biol. 2010, 396:9-18.
3. Fisk L., Nalivaeva N.N., Boyle J.P., Peers C.S., Turner A.J. Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem. Res. 2007, 32:1741-1748.
4. Gravina, S., Ho, L., Eckman, C., Long, K., Otvos Jr, L., Younkin, L., Suzuki, N. Younkin, S., 1995. Amyloid beta protein in Alzheimer's disease brain. J. Biol. Chem. 270, 7013-7017-7016.
5. Heim C., Zhang J., Lan J., Sieklucka M., Kurz T., Riederer P., Gerlach M., Sontag K.H. Cerebral oligaemia episode triggers free radical formation and late cognitive deficiencies. Eur. J. Neurosci. 2000, 12:715-725.
6. Hemming M.L., Patterson M., Reske-Nielsen C., Lin L., Isacson O., Selkoe D.J. Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease. PLoS Med. 2007, 4:e262.
7. Henon H., Durieu I., Guerouaou D., Lebert F., Pasquier F., Leys D. Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 2001, 57:1216-1222.
8. Iwata N., Tsubuki S., Takaki Y., Watanabe K., Sekiguchi M., Hosoki E., Kawashima-Morishima M., Lee H.J., Hama E., Sekine-Aizawa Y., Saido T.C. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 2000, 6:143-150.
9. Kalaria R.N., Bhatti S.U., Palatinsky E.A., Pennington D.H., Shelton E.R., Chan H.W., Perry G., Lust W.D. Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain. Neuroreport 1993, 4:211-214.
10. Kim J.J., Fanselow M.S. Modality-specific retrograde amnesia of fear. Science 1992, 256:675-677.
11. Li L., Zuo Z. Isoflurane preconditioning improves short-term and long-term neurological outcome after focal brain ischemia in adult rats. Neuroscience 2009, 164:497-506.
12. Liu S.F., Ye X., Malik A.B. Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. Circulation 1999, 100:1330-1337.
13. Malm T.M., Iivonen H., Goldsteins G., Keksa-Goldsteine V., Ahtoniemi T., Kanninen K., Salminen A., Auriola S., Van Groen T., Tanila H., Koistinaho J. Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden. J. Neurosci. 2007, 27:3712-3721.
14. Margaill I., Plotkine M., Lerouet D. Antioxidant strategies in the treatment of stroke. Free Radic. Biol. Med. 2005, 39:429-443.
15. Marr R.A., Guan H., Rockenstein E., Kindy M., Gage F.H., Verma I., Masliah E., Hersh L.B. Neprilysin regulates amyloid Beta peptide levels. J. Mol. Neurosci. 2004, 22:5-11.
16. Martin J.A., Smith B.L., Matthews T.J., Ventura S.J. Births and deaths: preliminary data for 1998. Natl. Vital Stat. Rep. 1999, 47:1-45.
17. Memezawa H., Minamisawa H., Smith M.-L., Siesjo B.K. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp. Brain Res. 1992, 89:67-78.
18. Miners J.S., Baig S., Palmer J., Palmer L.E., Kehoe P.G., Love S. Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol. 2008, 18:240-252.
19. Muangman P., Tamura R.N., Gibran N.S. Antioxidants inhibit fatty acid and glucose-mediated induction of neutral endopeptidase gene expression in human microvascular endothelial cells. J. Am. Coll. Surg. 2005, 200:208-215.
20. Nagasawa H., Kogure K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 1989, 20:1037-1043.
21. Nurmi A., Lindsberg P.J., Koistinaho M., Zhang W., Juettler E., Karjalainen-Lindsberg M.L., Weih F., Frank N., Schwaninger M., Koistinaho J. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 2004, 35:987-991.
22. Nurmi A., Vartiainen N., Pihlaja R., Goldsteins G., Yrjanheikki J., Koistinaho J. Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window. J. Neurochem. 2004, 91:755-765.
23. Qi J.P., Wu H., Yang Y., Wang D.D., Chen Y.X., Gu Y.H., Liu T. Cerebral ischemia and Alzheimer's disease: the expression of amyloid-beta and apolipoprotein E in human hippocampus. J. Alzheimers Dis. 2007, 12:335-341.
24. Reiserer R.S., Harrison F.E., Syverud D.C., McDonald M.P. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes Brain Behav. 2007, 6:54-65.
25. Rogers D.C., Campbell C.A., Stretton J.L., Mackay K.B. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 1997, 28:2060-2065.
26. Russo R., Borghi R., Markesbery W., Tabaton M., Piccini A. Neprylisin decreases uniformly in Alzheimer's disease and in normal aging. FEBS Lett. 2005, 579:6027-6030.
27. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N. Y. Acad. Sci. 2000, 924:17-25.
28. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
29. Shi J., Yang S.H., Stubley L., Day A.L., Simpkins J.W. Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res. 2000, 853:1-4.
30. Stephenson D.T., Rash K., Clemens J.A. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res. 1992, 593:128-135.
31. Stratmann G., Sall J.W., May L.D., Bell J.S., Magnusson K.R., Rau V., Visrodia K.H., Alvi R.S., Ku B., Lee M.T., Dai R. Isoflurane differentially affects neurogenesis and long-term neurocognitive function in 60-day-old and 7-day-old rats. Anesthesiology 2009, 110:834-848.
32. Takeo S., Niimura M., Miyake-Takagi K., Nagakura A., Fukatsu T., Ando T., Takagi N., Tanonaka K., Hara J. A possible mechanism for improvement by a cognition-enhancer nefiracetam of spatial memory function and cAMP-mediated signal transduction system in sustained cerebral ischaemia in rats. Br. J. Pharmacol. 2003, 138:642-654.
33. Tatemichi T.K., Desmond D.W., Mayeux R., Paik M., Stern Y., Sano M., Remien R.H., Williams J.B., Mohr J.P., Hauser W.A., Figueroa M. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992, 42:1185-1193.
34. Tesco G., Koh Y.H., Kang E.L., Cameron A.N., Das S., Sena-Esteves M., Hiltunen M., Yang S.H., Zhong Z., Shen Y., Simpkins J.W., Tanzi R.E. Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 2007, 54:721-737.
35. Thompson R.C., Herscovitch M., Zhao I., Ford T.J., Gilmore T.D. NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway. J. Biol. Chem. 2011, 286:1675-1682.
36. van Groen T., Puurunen K., Maki H.M., Sivenius J., Jolkkonen J. Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats. Stroke 2005, 36:1551-1556.
37. Vassar R., Citron M. Abeta-generating enzymes: recent advances in beta- and gamma-secretase research. Neuron 2000, 27:419-422.
38. Vermeer S.E., Prins N.D., den Heijer T., Hofman A., Koudstaal P.J., Breteler M.M. Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 2003, 348:1215-1222.
39. Wen Y., Onyewuchi O., Yang S., Liu R., Simpkins J.W. Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res. 2004, 1009:1-8.
40. Zhang Y., Xiong M., Yan R.Q., Sun F.Y. Mutant ubiquitin-mediated beta-secretase stability via activation of caspase-3 is related to beta-amyloid accumulation in ischemic striatum in rats. J. Cereb. Blood Flow Metab. 2010, 30:566-575.
41. Zhao P., Peng L., Li L., Xu X., Zuo Z. Isoflurane preconditioning improves long-term neurologic outcome after hypoxic-ischemic brain injury in neonatal rats. Anesthesiology 2007, 107:963-970.
42. Zheng S., Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of p38 mitogen-activated protein kinase. Mol. Pharmacol. 2004, 65:1172-1180.
43. Zou L.B., Mouri A., Iwata N., Saido T.C., Wang D., Wang M.W., Mizoguchi H., Noda Y., Nabeshima T. Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid Beta and impairment of learning and memory. J. Pharmacol. Exp. Ther. 2006, 317:334-340.